Skip to main content

Day: April 1, 2025

Bonduelle – Sale of our packaged salad business in Germany

BONDUELLE  Head office: “La Woestyne” – 59173 Renescure – FranceBonduelle a French S.C.A (Partnership limited by Shares) with a capital of 57 102 699,50 eurosRegistered under number : 447 250 044 ( Dunkerque Commercial and Companies Register)Press ReleaseVilleneuve d’Ascq, April 1, 2025 Sale of our packaged salad business in Germany The Bonduelle Group confirms that the assets relating to its packaged salad business in Germany have been sold to Taylor Farm on March 31, 2025. The completion of the project, announced in the Transform to Win transformation plan on August 29, marks an important step towards improving the group’s operating profitability. It will also enable the Bonduelle brand to maintain a strong presence in the German market through its canned and frozen food business, as well as in the packaged...

Continue reading

Karolinska Development’s portfolio company Umecrine Cognition presents promising preclinical Parkinson data at AD/PD 2025

STOCKHOLM, SWEDEN – April 1, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition presents recent preclinical data showing that golexanolone reverses dopamine loss and sustains improvements of Parkinsonian symptoms at the 19th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD) 2025, in Vienna, Austria, April 1–5th. Parkinson’s disease is a progressive neurodegenerative disease hallmarked by motor symptoms and disrupted cognitive functions as well as mental health. The disorder is caused by the loss of nerve cells in the brain that produce the signaling substance dopamine, which leads to various symptoms reducing the patient’s well-being and quality of life. Umecrine Cognition is developing a new class of drugs to alleviate cognitive symptoms. The company’s...

Continue reading

Termination of the lease agreement for the Laagri “Hortes” and conclusion of a new lease agreement with Rikets Aianduskeskus OÜ

On 24.05.2017, a lease agreement was concluded between the fund’s subsidiary EfTEN Seljaku OÜ as the landlord and Hortes AS (bankrupt) as the tenant, under which Hortes AS (bankrupt) used the properties at Seljaku 4b and 2a in Harju County, Saue municipality, Laagri hamlet, including the building with technical systems and facilities.  On 07.03.2025, the bankruptcy of Hortes AS (bankrupt) was declared by a court ruling. In this regard, EfTEN Seljaku OÜ demanded a guarantee from the tenant for the payment of future rent, ancillary costs as well as property maintenance and improvement costs and notified upon the cancellation of the lease agreement if the guarantee was not provided. Hortes AS (bankrupt) did not provide a guarantee, and the lease agreement expired on 31.03.2025.  From 01.04.2025, Rikets Aianduskeskus OÜ will start to operate...

Continue reading

Notice on Convening an Ordinary General Meeting of Shareholders of EPSO-G

In accordance with the initiative and decision of the Board of Energy Transmission and Exchange Group EPSO-G (legal entity code 302826889, registered address Laisvės pr. 10, Vilnius, Lithuania) the Ordinary General Meeting of EPSO-G shareholders is convened. Agenda of the EPSO-G Ordinary General Meeting of Shareholders: 1 Regarding taking note of the independent auditor’s report on the set of consolidated and Company 2024 financial statements of UAB EPSO-G UAB and the consolidated and Company  Management report of UAB EPSO-G for 2024; 2. Regarding taking note of the consolidated management report of UAB EPSO-G and the Company’s management report for 2024; 3. Regarding the approval of the set of consolidated and company’s financial statements of UAB EPSO-G for 2024; 4. Regarding the approval of the distribution of profit of...

Continue reading

Serstech publicerar årsredovisningen för 2024

Serstech AB (publ) meddelar att årsredovisningen för 2024 nu finns tillgänglig på bolagets webbplats, www.serstech.com. Årsredovisningen finns även bifogad i detta pressmeddelande. För mer information: Stefan Sandor, VD Serstech ABTelefon: 0739-60 60 67E-post: ss@serstech.com eller Thomas Pileby, Styrelseordförande Serstech ABTelefon: 0702-07 26 43E-post: tp@serstech.com eller besök: www.serstech.com Certified advisor åt Serstech är Svensk Kapitalmarknadsgranskning AB (SKMG). Om SerstechSerstech utvecklare och säljer utrustning för identifiering av farliga kemikalier, såsom narkotika, bomber och kemiska stridsmedel. Bolagets kunder är huvudsakligen rättsvårdande myndigheter och inkluderar FN, Världstullorganisationen (WCO) och tull- och polismyndigheter över hela världen. Serstech har återförsäljare i 63 länder. Bolaget har huvudkontor...

Continue reading

Awilco Drilling PLC: Ex-dividend USD 2.06 today

The shares in Awilco Drilling PLC (OSE: AWDR) will be traded ex dividend of USD 2.06 from today, 1 April 2025. Aberdeen, 1 April 2025For further information please contact: Eric Jacobs, CEO of Awilco Drilling PLCPhone: +47 9529 2271 Cathrine Haavind, IR ManagerPhone: +47 93 42 84 64Email: ch@awilcodrilling.com This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. 

Continue reading

EPSO-G group publishes consolidated audited operating and financial results for 2024

The New Energy Group EPSO-G (company code 302826889, registered office address Laisvės pr. 10, Vilnius, Lithuania). On March 31, the EPSO-G Board approved the EPSO-G and consolidated management report for 2024. Financial results The Group‘s adjusted EBITDA amounted to 73 million euros, an increase of 23% (59.2 million euros in 2023). The Group‘s Adjusted EBITDA increased due to the higher return on investment approved by the regulator (WACC for both the natural gas transmission operator and the electricity transmission operator increased by around 1 percentage point), as well as due to revenues of Energy cells recognised as grants, and due to the positive EBITDA of Group’s company Tetas (was -6.7 million euros in 2023). The adjusted net profit of EPSO-G group amounted to 41.9 million, and increased by 56.4% (in 2023, it reached 26.8 million...

Continue reading

Aspo has published its Annual Report 2024 

Aspo PlcStock Exchange ReleaseApril 1, 2025 at 09:45 am Aspo has published its Annual Report 2024  Aspo Group’s Annual Report 2024 has been published on the company’s website aspo.com.   The Annual Report 2024 includes the Strategy and Business Review, the Board of Directors’ Report, the Corporate Governance Statement and the Financial Statements 2024.  The Board of Directors’ Report includes the Sustainability Statement, which is based on the EU Corporate Sustainability Reporting Directive (CSRD). The audit firm Deloitte Oy has assured the Sustainability Statement at a limited assurance level.   The Consolidated Financial Statements are published in accordance with European Single Electronic Format (ESEF) reporting requirements, and it is available separately in XHTML format where the primary statements and the notes to the financial...

Continue reading

Prairie Provident Resources Announces Fourth Quarter and Year-End 2024 Financial and Operating Results, 2024 Year-End Reserves and Basal Quartz Update

CALGARY, Alberta, April 01, 2025 (GLOBE NEWSWIRE) — Prairie Provident Resources Inc. (“Prairie Provident” or the “Company”) (TSX:PPR) announces its operating and financial results for the fourth quarter and year ended December 31, 2024 and year-end reserves. Prairie Provident’s audited annual consolidated financial statements and related Management’s Discussion and Analysis (MD&A) for the year ended December 31, 2024 and Annual Information Form, dated March 31, 2025 for the same period are available on the Company’s website at www.ppr.ca and filed on SEDAR+ at www.sedarplus.ca. 2024 ANNUAL HIGHLIGHTSIn the first quarter of 2024, the Company sold its Evi assets in northern Alberta and certain non-core assets located in the Provost area of Central Alberta. Net proceeds of approximately CAD$24.2 million...

Continue reading

ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights

Received FDA authorization and recorded first commercial sales of ARC-EX System Secured strategic investment from Ottobock and extended cash runway for two years Gained exclusive rights to premier brain-computer interface technology EINDHOVEN, The Netherlands, April 01, 2025 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces its Full Year 2024 Financial and Operating Results. “2024 was a transformative year for ONWARD®, highlighted by our FDA De Novo authorization and first commercial sales of the ARC-EX® System,” said Dave Marver, CEO of ONWARD Medical. “We strengthened our balance sheet,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.